Publications
Valuing Health at the End of Life: A Stated Preference Discrete Choice Experiment
1 December 2012
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…
The R&D Cost of a New Medicine
1 December 2012
The cost of R&D for a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter not just because…
The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making
1 November 2012
The Humble Economist is an outstanding collection of the most important essays by Prof Tony Culyer, a founding father of health economics. It distils a powerful…
Value Based Pricing in Sweden: Lessons for Design?
11 January 2012
In this Seminar Briefing, Ulf Persson recounts Sweden’s experience with its approach to value based pricing (VBP). The model is a flexible approach that gives weight…
Causes of Death: A Study of a Century of Change in England and Wales
1 October 2012
This Briefing extends to 2007 Thomas McKeown’s well-known analysis of changes in life expectancy in England during 1901-1971. It finds that mortality continued to decline after 1971,…
International Comparisons of Medicines Prices: 2011 Indices
1 October 2012
Since 1996, in its yearly PPRS Report to Parliament, the Department of Health in England has published international price comparisons of branded medicines used in the…
Is There a Productivity Crisis in Pharmaceutical R&D?
6 January 2012
This Seminar Briefing recounts the key points made by Prof Riccaboni, from the University of Trento, at a recent OHE Lunchtime Seminar. It focuses primarily on…
The Many Faces of Innovation
1 June 2012
This report provides a clear explanation of the nature of innovation in medicines. A fully revised and expanded version of the 2005 edition, it updates the literature…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
Diagnostics not only facilitate health gain and cost savings, but also provide information to inform patients’ decisions on interventions and to clarify how their behaviour may…